Clinical Trials with Vitamin E in Cardiovascular Disease: Are they Meaningful?

• References

• 1 Violi F, Micheletta F, Iuliano L. Vitamin E Atherosclerosis and Thrombosis. Thromb Haemost 2001; 85: 766-70.
• 2 Marchioli R. Vitamin E and cardiovascular disease. Thromb Haemost 2001; 85: 758-60.
• 3 Rapola JM, Virtamo J, Ripatti S, Huttunen JK, Albanes D, taylor PR, Heinonen OP. Randomised trial of alpha-tocopherol and beta-carotene supplements on incidence of major coronary events in men with previous myocardial infarction. Lancet 1997; 349: 1715-20.
• 4 Stephens NG, Parsons A, Schofield PM, Kelly F, Cheesman K, Mitchinson MJ. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study. Lancet 1996; 347: 781-6.
• 5 Traber MG, Jialal I. Measurement of lipid-soluble vitamins: further adjustment needed?. Lancet 2000; 355: 2013-4.
• 6 Violi F, Micheletta F, Iuliano L. Antioxidant strategy for cardiovascular disease. Lancet 2001; 357: 1706.
• 7 Boaz M, Smetana S, Weinstein T, Gafter U, Iaina A, Knecht A, Weissgarten Y, Brunner D, Fainaru M, Green MS. Secondary prevention with anti-oxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial. Lancet 2000; 356: 1213-18.
• 8 Boaz M, Smetana S, Green MS. Vitamin E supplementation. Lancet 2001; 357: 632-3.